On Saturday, April 2, the Prof. Fabrizio Stocchi, Head of the Center for Parkinson's Disease Treatment and Diagnosis of the’IRCCS San Raffaele Pisana, Rome was interviewed on Magazine 7, a weekly current affairs program of La7, to take stock of the pathology and the new therapies for parkinson's disease currently most effective.
La parkinson's disease mainly affects movements, particularly the automatic movements that make up 90% of the movements we make every day. Patients affected by the Parkinson's They therefore encounter large difficulty in getting around And they are very slow and stiff.
Diagnosis is essentially clinical, that is, it is based on observation of the patient's symptoms; in fact, there is still no biomarker that evidences the presence of the disease, although there are ongoing studies in this regard. Moreover, it is a disease that increasingly affects young people: 1 in 4 unfortunately has an onset under the age of 50.
Prof. Fabrizio Stocchi, your center is among the best in Europe
The center headed by the Prof. Fabrizio Stocchi is a national reference in the field of motor and sensory rehabilitation and collaborates with many other European and American centers to develop clinical research aimed at improving existing therapies and testing new ones.
Four of these studies, coordinated by Prof. Fabrizio Stocchi and published last year in international medical and scientific journals, also covered the GONDOLA device®. Within the interview, the Prof. Fabrizio Stocchi also talks about the AMPS therapy dispensed with GONDOLA® and how stimulation helps patients regain their motor independence.
Italiano
Français
Deutsch
English